富蘭克林坦伯頓全球投資系列-生技領航基金美元F(acc)股
13.55美元0.04(0.3%)
2024/03/28更新
績效 / 1月4.05%
3月10.2%
1年31.55%
晨星評等-
- 1.現金2.49%
- 2.股票12.39%
- 3.債券0.00%
- 4.其他85.12%
- 1.美國84.51%
- 2.歐洲不包含歐元區3.99%
- 3.歐元區3.77%
- 4.英國3.61%
- 5.加拿大1.03%
- 1.Amgen Inc6.58%
- 2.Regeneron Pharmaceuticals Inc6.24%
- 3.Vertex Pharmaceuticals Inc5.20%
- 4.Ascendis Pharma A/S ADR3.99%
- 5.Gilead Sciences Inc2.92%
- 6.Intra-Cellular Therapies Inc2.81%
- 7.Biogen Inc2.80%
- 8.AstraZeneca PLC ADR2.75%
- 9.Jazz Pharmaceuticals PLC2.55%
- 10.Merus NV2.35%
- 1.現金2.49%
- 2.股票12.39%
- 3.債券0.00%
- 4.其他85.12%
- 1.美國84.51%
- 2.歐洲不包含歐元區3.99%
- 3.歐元區3.77%
- 4.英國3.61%
- 5.加拿大1.03%
- 1.Amgen Inc6.58%
- 2.Regeneron Pharmaceuticals Inc6.24%
- 3.Vertex Pharmaceuticals Inc5.20%
- 4.Ascendis Pharma A/S ADR3.99%
- 5.Gilead Sciences Inc2.92%
- 6.Intra-Cellular Therapies Inc2.81%
- 7.Biogen Inc2.80%
- 8.AstraZeneca PLC ADR2.75%
- 9.Jazz Pharmaceuticals PLC2.55%
- 10.Merus NV2.35%